Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kotyuk, Eszter ^a   Keszler, Gergely ^b   Nemeth, Nora ^b   Ronai, Zsolt ^b   Sasvari Szekely, Maria ^b   Szekely, Anna ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADULT; ANALYSIS OF COVARIANCE; ANXIETY; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GDNF GENE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ALLELES; ANXIETY; DEPRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SELF REPORT; SEX FACTORS; YOUNG ADULT;

EID: 84891916828     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080613     Document Type: Article

References (62)

1. Nitta A, Nishioka H, Fukumitsu H, Furukawa Y, Sugiura H, et al. (2004) Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. J Neurosci Res 78:250-258. (Pubitemid 39313798)
2. Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, et al. (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59:459-466. (Pubitemid 43358066)
3. Granholm AC, Reyland M, Albeck D, Sanders L, Gerhardt G, et al. (2000) Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J Neurosci 20:3182-3190. (Pubitemid 30263135)
4. Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394. (Pubitemid 135706635)
5. Hudson J, Granholm AC, Gerhardt GA, Henry MA, Hoffman A, et al. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425-432.
6. Cardoner N, Soria V, Gratacos M, Hernandez-Ribas R, Pujol J, et al. (2013) Val66met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome. Depress Anxiety 30:225-233.
7. Muinos-Gimeno M, Guidi M, Kagerbauer B, Martin-Santos R, Navines R, et al. (2009) Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30:1062-1071.
8. Faludi G, Gonda X, Bagdy G, Dome P (2012) Pharmaco- and therapygenetic aspects in the treatment of anxiety disorders beyond the serotonergic system: a brief review. Neuropsychopharmacol Hung 14:221-229.
9. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, et al. (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147 B: 1345-1354.
10. Alonso P, Lopez-Sola C, Gratacos M, Fullana MA, Segalas C, et al. (2013) The interaction between Comt and Bdnf variants influences obsessive- compulsiverelated dysfunctional beliefs. J Anxiety Disord 27:321-327.
11. Wang X, Hou Z, Yuan Y, Hou G, Liu Y, et al. (2011) Association study between plasma GDNF and cognitive function in late-onset depression. J Affect Disord 132:418-421.
12. Rosa AR, Frey BN, Andreazza AC, Cereser KM, Cunha AB, et al. (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407:146-150. (Pubitemid 44404148)
13. Tseng PT, Lee Y, Lin PY (2013) Age-associated decrease in serum glial cell linederived neurotrophic factor levels in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 40:334-339.
14. Diniz BS, Teixeira AL, Miranda AS, Talib LL, Gattaz WF, et al. (2012) Circulating Glial-derived neurotrophic factor is reduced in late-life depression. J Psychiatr Res 46:135-139.
15. Liu Q, Zhu HY, Li B, Wang YQ, Yu J, et al. (2012) Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression. J Affect Disord 141:367-372.
16. Golan M, Schreiber G, Avissar S (2011) Antidepressants elevate GDNF expression and release from C (6) glioma cells in a beta-arrestin1-dependent, CREB interactive pathway. Int J Neuropsychopharmacol 14:1289-1300.
17. Zhang X, Zhang Z, Sha W, Xie C, Xi G, et al. (2010) Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. J Affect Disord 126:326-329.
18. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, et al. (2011) Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69:359-372.
19. Michel TM, Frangou S, Camara S, Thiemeyer D, Jecel J, et al. (2008) Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry 23:413-420.
20. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, et al. (2006) Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 78:315-333. (Pubitemid 43157570)
21. Lee K, Kunugi H, Nanko S (2001) Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis. Psychiatry Res 104:11-17. (Pubitemid 32964781)
22. Michelato A, Bonvicini C, Ventriglia M, Scassellati C, Randazzo R, et al. (2004) 39 UTR (AGG) n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci Lett 357:235-237. (Pubitemid 38299266)
23. Williams HJ, Norton N, Peirce T, Dwyer S, Williams NM, et al. (2007) Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia. Schizophr Res 97:271-276. (Pubitemid 350088408)
24. Boor K, Ronai Z, Nemoda Z, Gaszner P, Sasvari-Szekely M, et al. (2002) Noninvasive genotyping of dopamine receptor D4 (DRD4) using nanograms of DNA from substance-dependent patients. Curr Med Chem 9:793-797. (Pubitemid 34506385)
25. Syed Z, Dudbridge F, Kent L (2007) An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am J Med Genet B Neuropsychiatr Genet 144 B: 375-378. (Pubitemid 46642033)
26. Cass WA, Peters LE, Harned ME, Seroogy KB (2006) Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine. Ann N Y Acad Sci 1074:272-281. (Pubitemid 44532830)
27. Yoshimura T, Usui H, Takahashi N, Yoshimi A, Saito S, et al. (2011) Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 35:1268-1272.
28. Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:247-257. (Pubitemid 43357471)
29. Muszbek K, Szekely A, Balogh EM, Molnar M, Rohanszky M, et al. (2006) Validation of the Hungarian translation of Hospital Anxiety and Depression Scale. Qual Life Res 15:761-766. (Pubitemid 43843983)
30. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370. (Pubitemid 13098606)
31. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
32. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169. (Pubitemid 37414228)
33. Stephens M, J. Smith N, Donnelly P (2003) Documentation for PHASE, version 2.0.2.
34. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989. (Pubitemid 32289743)
35. Hardy GH (1908) Mendelian Proportions in a Mixed Population. Science 28:49-50.
36. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552-1562.
37. McGuffin P, Katz R, Watkins S, Rutherford J (1996) A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry 53:129-136. (Pubitemid 26049389)
38. Stein MB, Jang KL, Livesley WJ (1999) Heritability of anxiety sensitivity: a twin study. Am J Psychiatry 156:246-251. (Pubitemid 29077116)
39. Serretti A, Smeraldi E (1999) Dopamine D2 receptor gene not associated with symptomatology of mood disorders. Am J Med Genet 88:294-297. (Pubitemid 29372238)
40. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, et al. (2001) Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105:145-151. (Pubitemid 32290577)
41. Serretti A, Lilli R, Lorenzi C, Lattuada E, Smeraldi E (2001) DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2, 011 affected subjects. Am J Med Genet 105:283-290. (Pubitemid 32410904)
42. Furukawa TA (2010) Assessment of mood: guides for clinicians. J Psychosom Res 68:581-589.
43. Smarr KL, Keefer AL (2011) Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 63 Suppl 11:S454-466.
44. Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 42:17-41. (Pubitemid 27095712)
45. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69-77. (Pubitemid 34192886)
46. Nagy G, Ronai Z, Somogyi A, Sasvari-Szekely M, Rahman OA, et al. (2008) P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients. Prog Neuropsychopharmacol Biol Psychiatry 32:1884-1888.
47. Hejjas K, Szekely A, Domotor E, Halmai Z, Balogh G, et al. (2009) Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. Am J Med Genet B Neuropsychiatr Genet 150 B: 295-299.
48. Everitt BS (2002) The Cambridge dictionary of Statistics. New York: Cambridge University Press; Second Edition.
49. Feingold A (1994) Gender differences in personality: a meta-analysis. Psychol Bull 116:429-456. (Pubitemid 24976779)
50. Lewinsohn PM, Gotlib IH, Lewinsohn M, Seeley JR, Allen NB (1998) Gender differences in anxiety disorders and anxiety symptoms in adolescents. J Abnorm Psychol 107:109-117. (Pubitemid 28102958)
51. Pigott TA (1999) Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 60 Suppl 18:4-15. (Pubitemid 29431907)
52. Halbreich U (1997) Hormonal interventions with psychopharmacological potential: an overview. Psychopharmacol Bull 33:281-286. (Pubitemid 27293120)
53. Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, et al. (2009) BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 34:382-388.
54. Lonka-Nevalaita L, Lume M, Leppanen S, Jokitalo E, Peranen J, et al. (2010) Characterization of the intracellular localization, processing, and secretion of two glial cell line-derived neurotrophic factor splice isoforms. J Neurosci 30:11403-11413.
55. Grimm L, Holinski-Feder E, Teodoridis J, Scheffer B, Schindelhauer D, et al. (1998) Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 39-UTR and alternative splice products. Hum Mol Genet 7:1873-1886. (Pubitemid 28499418)
56. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, et al. (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36:753-762.
57. Pandaranayaka PJ, Prasanthi N, Kannabiran N, Rangachari K, Dhivya M, et al. (2010) Polymorphisms in an intronic region of the myocilin gene associated with primary open-angle glaucoma-a possible role for alternate splicing. Mol Vis 16:2891-2902.
58. Kralovicova J, Gaunt TR, Rodriguez S, Wood PJ, Day IN, et al. (2006) Variants in the human insulin gene that affect pre-mRNA splicing: is-23HphI a functional single nucleotide polymorphism at IDDM2? Diabetes 55:260-264. (Pubitemid 43343323)
59. Lopez-Urrutia E, Valdes J, Bonilla-Moreno R, Martinez-Salazar M, Martinez-Garcia M, et al. (2012) A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants. Virus Res 166:43-53.
60. Ahmadiantehrani S, Ron D (2013) Dopamine D2 Receptor Activation Leads To An Upregulation Of Glial Cell Line-Derived Neurotrophic Factor Via Gbetagamma-Erk1/2-Dependent Induction Of Zif268. J Neurochem.
61. Breslau N (1995) Psychiatric sequelae of low birth weight. Epidemiol Rev 17:96-106.
62. Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, et al. (2001) Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 179:432-437. (Pubitemid 33097166)